SD Biosensor Signs Diagnostic Kit Supply Contract Worth 148.3 Billion KRW

[Asia Economy Reporter Myunghwan Lee] SD Biosensor announced on the 18th that it has signed a supply contract with the Japanese government for COVID-19 and influenza simultaneous diagnostic kits and COVID-19 self-test kits worth 148.34209 billion KRW.

This amount corresponds to 5.06% of last year's sales revenue. The contract period is until November 30.

An SD Biosensor official stated, "The Japanese government is considering managing COVID-19 and influenza at the same level, which seems to have increased the demand for simultaneous diagnostic kits," adding, "We will do our best to quickly supply simultaneous diagnostic products that can easily identify infections of COVID-19 and influenza worldwide."